Kainos Medicine, Inc. (KOSDAQ:284620)

Kainos Medicine Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2014	FY 2013
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2014	Dec 31, 2013
Revenue	-	-	-	145.28	100
Revenue Growth (YoY)	-	-	-	45.28%	1100.05%
Cost of Revenue	-	-	-	25.07	1.61
Gross Profit	-	-	-	120.22	98.39
Selling, General & Admin	-	-	-	967.48	1,271
Research & Development	-	-	-	1,257	1,151
Other Operating Expenses	-44.18	-25.92	-42.27	6.41	3.46
Operating Expenses	-44.18	-25.92	-42.27	2,238	2,516
Operating Income	44.18	25.92	42.27	-2,117	-2,417
Interest & Investment Income	-	-	-	27.71	35.79
Earnings From Equity Investments	-	-	-	-3.79	27.26
Currency Exchange Gain (Loss)	-	-	-	4.41	-0.68
Other Non Operating Income (Expenses)	-	-	-29.41	5.34	-25.38
EBT Excluding Unusual Items	44.18	25.92	12.86	-2,084	-2,380
Gain (Loss) on Sale of Assets	-	-	-	15.3	-54.39
Asset Writedown	-	-	-	-	-6,719
Other Unusual Items	-	-	-	-	3,354
Pretax Income	44.18	25.92	12.86	-2,068	-5,800
Income Tax Expense	20.82	21.97	-25.07	-	-
Net Income	23.36	3.95	37.93	-2,068	-5,800
Net Income to Common	23.36	3.95	37.93	-2,068	-5,800
Net Income Growth	491.64%	-89.59%	-	-	-
Shares Outstanding (Basic)	5	0	-	9	8
Shares Outstanding (Diluted)	5	0	-	9	8
Shares Change (YoY)	1405.00%	-	-	15.34%	9.20%
EPS (Basic)	4.32	11.00	-	-235.00	-760.00
EPS (Diluted)	4.32	11.00	-	-235.00	-760.00
EPS Growth	-60.69%	-	-	-	-
Free Cash Flow	185.74	-22.01	-27.23	-2,072	-3,281
Free Cash Flow Per Share	34.39	-61.33	-	-235.44	-429.90
Gross Margin	-	-	-	82.75%	98.39%
Operating Margin	-	-	-	-1457.48%	-2417.34%
Profit Margin	-	-	-	-1423.77%	-5799.98%
Free Cash Flow Margin	-	-	-	-1426.41%	-3280.83%
EBITDA	-	-	-	-2,076	-2,307
D&A For EBITDA	-	-	-	41.8	110.09
EBIT	44.18	25.92	42.27	-2,117	-2,417
Effective Tax Rate	47.13%	84.77%	-	-	-

Updated Apr 30, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.